These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2358843)

  • 21. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma.
    Chao YK; Yeh CJ; Chang HK; Tseng CK; Chu YY; Hsieh MJ; Wu YC; Liu HP
    Ann Surg Oncol; 2011 Feb; 18(2):529-34. PubMed ID: 20697822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reply to Letter: "Residual Esophageal Cancer After Neoadjuvant Chemoradiotherapy Frequently Involves the Mucosa and Submucosa".
    Shapiro J; Wijnhoven BP; van Lanschot JJ
    Ann Surg; 2015 Aug; 262(2):e84-5. PubMed ID: 24743617
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of clinical T2N0M0 esophageal cancer.
    Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
    Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trials in the treatment of cancer of the esophagus.
    Girling DJ; Clark PI
    J Clin Oncol; 1992 Jul; 10(7):1031-3. PubMed ID: 1607910
    [No Abstract]   [Full Text] [Related]  

  • 25. Residual Esophageal Cancer After Neoadjuvant Chemoradiotherapy Frequently Involves the Mucosa and Submucosa.
    van Rossum PSN; van Hillegersberg R; Meijer GJ; Ruurda JP
    Ann Surg; 2015 Aug; 262(2):e83-4. PubMed ID: 24743619
    [No Abstract]   [Full Text] [Related]  

  • 26. Palliation of carcinoma of the esophagus: is there a hope for cure?
    Lambert R
    Am J Gastroenterol; 1994 Aug; 89(8 Suppl):S27-40. PubMed ID: 7519392
    [No Abstract]   [Full Text] [Related]  

  • 27. Early detection and management of esophageal cancer.
    Margulies C; Kim R; Reynolds JC
    Compr Ther; 1996 Sep; 22(9):565-78. PubMed ID: 8902348
    [No Abstract]   [Full Text] [Related]  

  • 28. A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92.
    Becerra CR; Hanna N; McCollum AD; Becharm N; Timmerman RD; DiMaio M; Kesler KA; Yu M; Yan T; Choy H
    J Thorac Oncol; 2013 Nov; 8(11):1425-9. PubMed ID: 24084441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radiotherapy of esophageal cancer in combination with chemotherapy].
    Jinnouchi S; Koga K; Nishikawa K; Kihara Y; Kusuhara T; Watanabe K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Nov; 43(11):1278-83. PubMed ID: 6672755
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic significance of age in the radical treatment of oesophageal cancer with surgery or chemoradiotherapy: a prospective observational cohort study.
    Davies L; Lewis WG; Arnold DT; Escofet X; Blackshaw G; Gwynne S; Evans M; Roberts SA; Appadurai I; Crosby TD
    Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):578-85. PubMed ID: 20591633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System: a 10-year experience.
    González Ortiz DI; Toro DH
    Bol Asoc Med P R; 2009; 101(3):14-7. PubMed ID: 20120980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined-modality therapy for esophageal cancer: are we making progress?
    Gibson MK; Forastiere AA
    Cancer J; 2003; 9(4):238-40. PubMed ID: 12967131
    [No Abstract]   [Full Text] [Related]  

  • 33. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
    Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
    Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Squamous cell esophageal carcinoma as a second primary malignancy in a woman with epithelial ovarian cancer.
    Karagiannis S; Papadimitriou CA; Sotiropoulou M; Dimopoulos F; Chrysanthopoulou H; Dimopoulos MA; Michopoulos S
    Dig Dis Sci; 2007 Nov; 52(11):3099-101. PubMed ID: 17393316
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic strategies for advanced respectable esophageal cancer].
    Kitagawa Y
    Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):333-7. PubMed ID: 19068714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combination therapy of radiation and bleomycin for esophageal carcinoma, with special reference to the prognostic aspect].
    Yamada S; Asakawa H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Oct; 43(10):1183-93. PubMed ID: 6200824
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer.
    Narumiya K; Metzger R; Bollschweiler E; Alakus H; Brabender J; Drebber U; Hölscher AH; Warnecke-Eberz U
    Pharmacogenomics; 2011 Feb; 12(2):205-14. PubMed ID: 21332314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic therapy of esophago-gastric tumors.
    Lambert R
    Endoscopy; 1992; 24(1-2):24-33. PubMed ID: 1373114
    [No Abstract]   [Full Text] [Related]  

  • 39. Oesophageal carcinoma: combined chemo- and radiotherapy.
    Dehn TC; Jamieson GG; Gill PG
    Br J Surg; 1988 Jun; 75(6):621. PubMed ID: 3395833
    [No Abstract]   [Full Text] [Related]  

  • 40. Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer.
    Griffin JM; Reed CE; Denlinger CE
    Ann Thorac Surg; 2012 Jun; 93(6):1855-9; discussion 1860. PubMed ID: 22516835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.